CY2010013I2 - Ανοσογονες lhrh συνθεσεις και μεθοδοι που σχετιζονται με αυτες - Google Patents

Ανοσογονες lhrh συνθεσεις και μεθοδοι που σχετιζονται με αυτες

Info

Publication number
CY2010013I2
CY2010013I2 CY2010013C CY2010013C CY2010013I2 CY 2010013 I2 CY2010013 I2 CY 2010013I2 CY 2010013 C CY2010013 C CY 2010013C CY 2010013 C CY2010013 C CY 2010013C CY 2010013 I2 CY2010013 I2 CY 2010013I2
Authority
CY
Cyprus
Prior art keywords
immunogeneous
methods related
lhrh compositions
lhrh
compositions
Prior art date
Application number
CY2010013C
Other languages
English (en)
Other versions
CY2010013I1 (el
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of CY2010013I2 publication Critical patent/CY2010013I2/el
Publication of CY2010013I1 publication Critical patent/CY2010013I1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0006Contraceptive vaccins; Vaccines against sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
CY2010013C 1997-07-09 2010-07-07 Ανοσογονες lhrh συνθεσεις και μεθοδοι που σχετιζονται με αυτες CY2010013I1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO7768A AUPO776897A0 (en) 1997-07-09 1997-07-09 A method of achieving production gains in livestock and agents useful for same
PCT/AU1998/000532 WO1999002180A1 (en) 1997-07-09 1998-07-09 Immunogenic lhrh compositions and methods relating thereto

Publications (2)

Publication Number Publication Date
CY2010013I2 true CY2010013I2 (el) 2012-01-25
CY2010013I1 CY2010013I1 (el) 2012-01-25

Family

ID=3802056

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20101100331T CY1109968T1 (el) 1997-07-09 2010-04-13 Ανοσογονες lhrh συνθεσεις και μεθοδοι που σχετιζονται με αυτες
CY2010013C CY2010013I1 (el) 1997-07-09 2010-07-07 Ανοσογονες lhrh συνθεσεις και μεθοδοι που σχετιζονται με αυτες

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20101100331T CY1109968T1 (el) 1997-07-09 2010-04-13 Ανοσογονες lhrh συνθεσεις και μεθοδοι που σχετιζονται με αυτες

Country Status (19)

Country Link
US (6) US7534441B2 (el)
EP (4) EP1007084B1 (el)
JP (3) JP5116916B2 (el)
KR (2) KR20060101554A (el)
AT (1) ATE458493T1 (el)
AU (2) AUPO776897A0 (el)
CA (1) CA2294865C (el)
CY (2) CY1109968T1 (el)
DE (2) DE122010000033I1 (el)
DK (1) DK1007084T3 (el)
ES (1) ES2339308T3 (el)
FR (2) FR10C0035I2 (el)
LU (1) LU91711I2 (el)
NZ (1) NZ502080A (el)
PL (1) PL200495B1 (el)
PT (1) PT1007084E (el)
TW (1) TWI235666B (el)
WO (1) WO1999002180A1 (el)
ZA (1) ZA986074B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
DE60017211T2 (de) 1999-02-17 2005-06-02 Pfizer Products Inc., Groton Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
AU2005281743A1 (en) * 2004-08-04 2006-03-16 Cytos Biotechnology Ag Carrier conjugates of GnRH-peptides
RU2007143992A (ru) * 2005-06-01 2009-07-20 Пфайзер Продактс Инк. (Us) Вакцинные композиции и способы лечения недержания мочи
WO2008110912A1 (en) * 2007-03-14 2008-09-18 Pfizer Inc. Fertility regulation in horses
AP2015008444A0 (en) 2012-12-03 2015-05-31 Pfizer Novel selective androgen receptor modulators
KR101918381B1 (ko) * 2017-01-11 2018-11-13 이경민 칠보 공예품을 제조하는 방법과 이에 의하여 제조되는 칠보 공예품
KR102477054B1 (ko) * 2020-03-24 2022-12-14 주식회사 바이오앱 웅취 제거용 재조합 단백질 및 이를 포함하는 백신 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
DE3411224A1 (de) 1984-03-27 1985-10-10 Hoechst Ag, 6230 Frankfurt Verfahren zur racematarmen herstellung von peptidzwischenprodukten der gonadorelin- und gonadorelinanaloga-synthese und neue zwischenprodukte bei diesem verfahren
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
NZ221306A (en) * 1986-08-15 1990-02-26 Commw Scient Ind Res Org 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
AU602187B2 (en) * 1987-01-14 1990-10-04 Commonwealth Scientific And Industrial Research Organisation Anti-reproductive hormone
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
AU5186090A (en) * 1989-02-23 1990-09-26 Colorado State University Research Foundation Gnrh analogs for destroying gonadotrophs
NL8900726A (nl) 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
ATE140972T1 (de) * 1989-08-25 1996-08-15 Biotech Australia Pty Ltd Fusionsproteine bestehend aus tratp und mindestens einem lhrh-analog
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JP3177246B2 (ja) * 1991-03-01 2001-06-18 メリアル 未去勢のオスの家畜に対する抗lhrh免疫方法と、そのためのペプチド
ATE191147T1 (de) * 1991-07-26 2000-04-15 Commw Scient Ind Res Org System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
ZA934199B (en) * 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
US5614487A (en) * 1993-05-28 1997-03-25 Genentech, Inc. Sustained release pharmaceutical composition
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
EP0832107B1 (en) 1995-06-07 2001-09-05 DLO Instituut voor Dierhouderij en Diergezondheid An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine
USRE39048E1 (en) * 1995-06-07 2006-03-28 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
WO1997015316A1 (en) 1995-10-27 1997-05-01 Merck & Co., Inc. Conjugates of gonadotropin releasing hormone
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6013770A (en) * 1997-07-21 2000-01-11 Washington State University Chimeric contraceptive vaccines

Also Published As

Publication number Publication date
US8741303B2 (en) 2014-06-03
US20140271695A1 (en) 2014-09-18
ATE458493T1 (de) 2010-03-15
FR10C0040I1 (fr) 2010-10-15
CY2010013I1 (el) 2012-01-25
EP2191839A2 (en) 2010-06-02
KR100680631B1 (ko) 2007-02-09
AUPO776897A0 (en) 1997-07-31
ZA986074B (en) 1999-03-16
PL200495B1 (pl) 2009-01-30
WO1999002180A1 (en) 1999-01-21
US20090226484A1 (en) 2009-09-10
JP5116916B2 (ja) 2013-01-09
EP1007084B1 (en) 2010-02-24
EP1007084A4 (en) 2003-07-02
NZ502080A (en) 2001-09-28
EP2316477A1 (en) 2011-05-04
DE122010000033I1 (de) 2011-12-01
TWI235666B (en) 2005-07-11
KR20060101554A (ko) 2006-09-25
LU91711I2 (fr) 2010-09-28
ES2339308T3 (es) 2010-05-18
AU725562B2 (en) 2000-10-12
JP2010059167A (ja) 2010-03-18
PL338037A1 (en) 2000-09-25
US20120328639A1 (en) 2012-12-27
KR20010021623A (ko) 2001-03-15
DE69841521D1 (de) 2010-04-08
JP2013006862A (ja) 2013-01-10
EP2196213A1 (en) 2010-06-16
CA2294865C (en) 2013-05-21
US20060024290A1 (en) 2006-02-02
CA2294865A1 (en) 1999-01-21
CY1109968T1 (el) 2012-01-25
US20110293647A1 (en) 2011-12-01
FR10C0035I2 (fr) 2012-06-22
FR10C0035I1 (fr) 2010-08-27
US7534441B2 (en) 2009-05-19
JP5231378B2 (ja) 2013-07-10
EP2191839A3 (en) 2010-09-08
US20090291098A1 (en) 2009-11-26
JP2001509489A (ja) 2001-07-24
AU8200198A (en) 1999-02-08
EP1007084A1 (en) 2000-06-14
DK1007084T3 (da) 2010-05-03
PT1007084E (pt) 2010-04-08

Similar Documents

Publication Publication Date Title
CY2010013I1 (el) Ανοσογονες lhrh συνθεσεις και μεθοδοι που σχετιζονται με αυτες
CY2009008I2 (el) Gnrh ανταγωνιστες τροποποιημενοι στις θεσεις 5 και 6
DE69815565D1 (de) Pestizide Zusammensetzungen
NO20001631L (no) 2-metyl-tieno-benzodiazepin formulering
BR9710053A (pt) Composições pesticidas
ATE242971T1 (de) Pestizide zusammensetzungen
ID17241A (id) Komposisi-komposisi pestisida
ID22931A (id) Komposisi-komposisi herbisidal
FI974241A (fi) BPM-15 -koostumukset
DE69841883D1 (de) Rheologieveränderte thermoplastische elastomerzusammensetzungen und gegenstände daraus
DK1298194T3 (da) Staniolholdige sammensætninger
DE69824961D1 (de) Härtbare zusammensetzung
NO996108D0 (no) 9-oksinerytromycinderivater
ATE243416T1 (de) Pestizid-zusammensetzungen
PT996418E (pt) Composicoes dermatologicas
ATE245356T1 (de) Pestizidzusammensetzungen
FR2783711B1 (fr) Compositions cosmetiques photoprotectrices et utilisations
ID25650A (id) Komposisi-komposisi sampo
PT1017281E (pt) Metodos e composicoes herbicidas sinergicas
ATE231685T1 (de) Pestizide zusammensetzungen
NO995147D0 (no) Kontrastmidler
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
PT811593E (pt) Agentes insecticidas e acaricidas 1,4-diaril-2-fluor-2-buteno
NO985079D0 (no) Eksplosiv formulering
NO985111D0 (no) Eksplosiv formulering